Andrea Pellacani

2.9k total citations · 1 hit paper
48 papers, 2.1k citations indexed

About

Andrea Pellacani is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Andrea Pellacani has authored 48 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 12 papers in Surgery and 11 papers in Oncology. Recurrent topics in Andrea Pellacani's work include Orthopaedic implants and arthroplasty (6 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and HER2/EGFR in Cancer Research (4 papers). Andrea Pellacani is often cited by papers focused on Orthopaedic implants and arthroplasty (6 papers), Heme Oxygenase-1 and Carbon Monoxide (5 papers) and HER2/EGFR in Cancer Research (4 papers). Andrea Pellacani collaborates with scholars based in Italy, United States and Spain. Andrea Pellacani's co-authors include Mark A. Perrella, Massimo Cugno, Marco Cicardi, Juerg Nussberger, C Amstutz, Philippe Wiesel, Shaw‐Fang Yet, Lauren C. Foster, Jürg Nussberger and Michael T. Chin and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Andrea Pellacani

45 papers receiving 2.1k citations

Hit Papers

Plasma bradykinin in angio-oedema 1998 2026 2007 2016 1998 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Plasma bradykinin in angio-oedema
    1998 553 citations Juerg Nussberger, Massimo Cugno et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Pellacani Italy 21 1.0k 588 342 257 243 48 2.1k
Uta Kunter Germany 29 1.1k 1.1× 494 0.8× 378 1.1× 248 1.0× 106 0.4× 49 3.0k
Christoph Otto Germany 28 869 0.9× 335 0.6× 269 0.8× 477 1.9× 248 1.0× 133 2.8k
Fujio Shimizu Japan 35 1.4k 1.4× 283 0.5× 569 1.7× 311 1.2× 188 0.8× 118 3.7k
Changli Wei United States 27 1.2k 1.2× 580 1.0× 651 1.9× 663 2.6× 273 1.1× 61 4.2k
Mehmet M. Altintas United States 20 982 1.0× 300 0.5× 380 1.1× 221 0.9× 79 0.3× 45 2.7k
Takahito Ito Japan 27 1.5k 1.5× 461 0.8× 154 0.5× 198 0.8× 122 0.5× 78 2.7k
Daniela Rottoli Italy 32 1.5k 1.5× 965 1.6× 492 1.4× 357 1.4× 120 0.5× 47 4.1k
Lorena Longaretti Italy 25 1.3k 1.3× 517 0.9× 343 1.0× 225 0.9× 74 0.3× 42 3.1k
Takatoshi Koyama Japan 28 504 0.5× 176 0.3× 347 1.0× 334 1.3× 98 0.4× 92 2.0k
Mahsa M. Amoli Iran 26 838 0.8× 177 0.3× 572 1.7× 195 0.8× 434 1.8× 186 2.7k

Countries citing papers authored by Andrea Pellacani

Since Specialization
Citations

This map shows the geographic impact of Andrea Pellacani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Pellacani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Pellacani more than expected).

Fields of papers citing papers by Andrea Pellacani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Pellacani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Pellacani. The network helps show where Andrea Pellacani may publish in the future.

Co-authorship network of co-authors of Andrea Pellacani

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Pellacani. A scholar is included among the top collaborators of Andrea Pellacani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Pellacani. Andrea Pellacani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Merlino, G., Mario Bigioni, Patrizia Tunici, et al.. (2021). 489P MEN1611 in combination with cetuximab: Targeting PIK3CA mutations in RAS-wild-type patient-derived colorectal cancer xenografts. Annals of Oncology. 32. S573–S573. 2 indexed citations
2.
3.
4.
5.
Preiss, David, Dirk Blom, C. Stephen Djedjos, et al.. (2015). Evaluation of the one-year efficacy, safety and glycaemic effects of evolocumab (AMG 145) in 4,802 subjects with, at high risk for, or at low risk for, diabetes mellitus. Diabetologia. 58. 6 indexed citations
6.
Preiss, David, Naveed Sattar, J Robinson, et al.. (2015). Efficacy of one year of treatment with the PCSK9 inhibitor evolocumab (AMG 145) in 4,802 subjects with or without type 2 diabetes. Diabetologia. 58.
7.
Hale, Clarence, David J. Lloyd, Andrea Pellacani, & Murielle M. Véniant. (2014). Molecular targeting of the GK-GKRP pathway in diabetes. Expert Opinion on Therapeutic Targets. 19(1). 129–139. 16 indexed citations
8.
Savarino, L., Nicola Baldini, G. Ciapetti, Andrea Pellacani, & Armando Giunti. (2009). Is wear debris responsible for failure in alumina-on-alumina implants?. Acta Orthopaedica. 80(2). 162–167. 15 indexed citations
9.
Granchi, Donatella, Sofia Avnet, S. Capaccioli, et al.. (2004). In vitro blockade of receptor activator of nuclear factor‐κB ligand prevents osteoclastogenesis induced by neuroblastoma cells. International Journal of Cancer. 111(6). 829–838. 42 indexed citations
10.
Dallari, Dante, et al.. (2003). Xanthoma of Bone: First Sign of Hyperlipidemia Type IIB. Clinical Orthopaedics and Related Research. 410(410). 274–277. 16 indexed citations
11.
Pellacani, Andrea, Philippe Wiesel, Mark W. Feinberg, et al.. (2001). Down-regulation of High Mobility Group-I(Y) Protein Contributes to the Inhibition of Nitric-oxide Synthase 2 by Transforming Growth Factor-β1. Journal of Biological Chemistry. 276(2). 1653–1659. 29 indexed citations
12.
Rudders, Susan A., John Gaspar, Carole Voland, et al.. (2001). ESE-1 Is a Novel Transcriptional Mediator of Inflammation That Interacts with NF-κB to Regulate the Inducible Nitric-oxide Synthase Gene. Journal of Biological Chemistry. 276(5). 3302–3309. 84 indexed citations
13.
Wiesel, Philippe, Lauren C. Foster, Andrea Pellacani, et al.. (2000). Thioredoxin Facilitates the Induction of Heme Oxygenase-1 in Response to Inflammatory Mediators. Journal of Biological Chemistry. 275(32). 24840–24846. 107 indexed citations
14.
Foster, Lauren C., Philippe Wiesel, Gordon S. Huggins, et al.. (2000). Role of activating protein‐1 and high mobility group‐I(Y) protein in the induction of CD44 gene expression by interleukin‐1β in vascular smooth muscle cells. The FASEB Journal. 14(2). 368–378. 45 indexed citations
15.
Pellacani, Andrea, Michael T. Chin, Philippe Wiesel, et al.. (1999). Induction of High Mobility Group-I(Y) Protein by Endotoxin and Interleukin-1β in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 274(3). 1525–1532. 36 indexed citations
16.
Chin, Michael T., Andrea Pellacani, Sharon Lin, et al.. (1999). Induction of High Mobility Group I Architectural Transcription Factors in Proliferating Vascular Smooth Muscle in vivo and in vitro. Journal of Molecular and Cellular Cardiology. 31(12). 2199–2205. 15 indexed citations
17.
Perrella, Mark A., Andrea Pellacani, Philippe Wiesel, et al.. (1999). High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer. Journal of Biological Chemistry. 274(13). 9045–9052. 53 indexed citations
18.
Nussberger, Juerg, et al.. (1998). Plasma bradykinin in angio-oedema. The Lancet. 351(9117). 1693–1697. 553 indexed citations breakdown →
19.
Chin, Michael T., Andrea Pellacani, Hong Wang, et al.. (1998). Enhancement of Serum-response Factor-dependent Transcription and DNA Binding by the Architectural Transcription Factor HMG-I(Y). Journal of Biological Chemistry. 273(16). 9755–9760. 65 indexed citations
20.
Pellacani, Andrea, H R Brunner, & Jürg Nussberger. (1992). Antagonizing and Measurement: Approaches to Understanding of Hemodynamic Effects of Kinins. Journal of Cardiovascular Pharmacology. 20(Supplement 9). S28–S34. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Uta Kunter Breakdown of academic impact, for papers by Christoph Otto Breakdown of academic impact, for papers by Fujio Shimizu Breakdown of academic impact, for papers by Changli Wei Breakdown of academic impact, for papers by Mehmet M. Altintas Breakdown of academic impact, for papers by Takahito Ito Breakdown of academic impact, for papers by Daniela Rottoli Breakdown of academic impact, for papers by Lorena Longaretti Breakdown of academic impact, for papers by Takatoshi Koyama Breakdown of academic impact, for papers by Mahsa M. Amoli
Rankless by CCL
2026